93 related articles for article (PubMed ID: 3167611)
1. Treatment of unresectable pancreatic carcinoma using irradiation with concurrent intravenous 5-FU infusion therapy.
Raju PI; Maruyama Y; MacDonald J; DeSimone P
Cancer Invest; 1988; 6(3):263-6. PubMed ID: 3167611
[TBL] [Abstract][Full Text] [Related]
2. Phase I trial of low dose N-phosphonacetyl-L-aspartic acid and high dose 5-fluorouracil administered concomitantly with radiation therapy for unresectable localized adenocarcinoma of the pancreas.
Ardalan B; Ucar A; Reddy R; Livingstone AS; Markoe A; Schwade J; Richman SP; Donofrio K
Cancer; 1994 Oct; 74(7):1869-73. PubMed ID: 8082092
[TBL] [Abstract][Full Text] [Related]
3. Protracted venous infusion 5-fluorouracil with concomitant radiotherapy compared with bolus 5-fluorouracil for unresectable pancreatic cancer.
Mehta VK; Poen JC; Ford JM; Oberhelman HA; Vierra MA; Bastidas AJ; Fisher GA
Am J Clin Oncol; 2001 Apr; 24(2):155-9. PubMed ID: 11319291
[TBL] [Abstract][Full Text] [Related]
4. High-dose local irradiation plus prophylactic hepatic irradiation and chemotherapy for inoperable adenocarcinoma of the pancreas. A preliminary report of a multi-institutional trial (Radiation Therapy Oncology Group Protocol 8801).
Komaki R; Wadler S; Peters T; Byhardt RW; Order S; Gallagher MJ; Herskovic A; Pederson J
Cancer; 1992 Jun; 69(11):2807-12. PubMed ID: 1571912
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma.
Keene KS; Rich TA; Penberthy DR; Shepard RC; Adams R; Jones RS
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):97-103. PubMed ID: 15850908
[TBL] [Abstract][Full Text] [Related]
6. Arterial infusion of 5-fluorouracil combined with concurrent radiotherapy for unresectable pancreatic cancer: results from a pilot study.
Tanaka T; Sakaguchi H; Anai H; Yamamoto K; Morimoto K; Tamamoto T; Kichikawa K
AJR Am J Roentgenol; 2007 Aug; 189(2):421-8. PubMed ID: 17646470
[TBL] [Abstract][Full Text] [Related]
7. Concomitant intraarterial cisplatin, intravenous 5-flourouracil, and split-course radiation therapy for locally advanced unresectable pancreatic adenocarcinoma: a phase II study of the Puget Sound Oncology Consortium (PSOC-703).
Thomas CR; Weiden PL; Traverso LW; Thompson T
Am J Clin Oncol; 1997 Apr; 20(2):161-5. PubMed ID: 9124192
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A Phase II Study.
Yeung RS; Weese JL; Hoffman JP; Solin LJ; Paul AR; Engstrom PF; Litwin S; Kowalyshyn MJ; Eisenberg BL
Cancer; 1993 Oct; 72(7):2124-33. PubMed ID: 8374871
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative and conformal external-beam radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic carcinoma.
Furuse J; Kinoshita T; Kawashima M; Ishii H; Nagase M; Konishi M; Nakagohri T; Inoue K; Ogino T; Ikeda H; Maru Y; Yoshino M
Cancer; 2003 Mar; 97(5):1346-52. PubMed ID: 12599244
[TBL] [Abstract][Full Text] [Related]
10. Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma: a phase I Eastern Cooperative Oncology Group Trial.
Whittington R; Neuberg D; Tester WJ; Benson AB; Haller DG
J Clin Oncol; 1995 Jan; 13(1):227-32. PubMed ID: 7799024
[TBL] [Abstract][Full Text] [Related]
11. Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study.
Klaassen DJ; MacIntyre JM; Catton GE; Engstrom PF; Moertel CG
J Clin Oncol; 1985 Mar; 3(3):373-8. PubMed ID: 3973648
[TBL] [Abstract][Full Text] [Related]
12. Pilot study in locally advanced unresectable pancreas carcinoma using a combination of accelerated radiotherapy and continuous infusion of 5-fluorouracil.
Luderhoff EC; González González D; Bakker P
Radiother Oncol; 1996 Sep; 40(3):241-3. PubMed ID: 8940751
[TBL] [Abstract][Full Text] [Related]
13. 5-fluorouracil-based chemoradiation in unresectable pancreatic carcinoma: Phase I-II dose-escalation study.
Morganti AG; Valentini V; Macchia G; Mattiucci GC; Costamagna G; Deodato F; Smaniotto D; Luzi S; Balducci M; Barbi S; Perri V; Trodella L; Cellini N
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1454-60. PubMed ID: 15275732
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy and continuous infusion 5-fluorouracil in patients with nonresectable pancreatic carcinoma.
Boz G; De Paoli A; Innocente R; Rossi C; Tosolini G; Pederzoli P; Talamini R; Trovò MG
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):736-40. PubMed ID: 11597816
[TBL] [Abstract][Full Text] [Related]
15. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group.
Moertel CG; Frytak S; Hahn RG; O'Connell MJ; Reitemeier RJ; Rubin J; Schutt AJ; Weiland LH; Childs DS; Holbrook MA; Lavin PT; Livstone E; Spiro H; Knowlton A; Kalser M; Barkin J; Lessner H; Mann-Kaplan R; Ramming K; Douglas HO; Thomas P; Nave H; Bateman J; Lokich J; Brooks J; Chaffey J; Corson JM; Zamcheck N; Novak JW
Cancer; 1981 Oct; 48(8):1705-10. PubMed ID: 7284971
[TBL] [Abstract][Full Text] [Related]
16. Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study.
Al-Sukhun S; Zalupski MM; Ben-Josef E; Vaitkevicius VK; Philip PA; Soulen R; Weaver D; Adsay V; Heilbrun LK; Levin K; Forman JD; Shields AF
Am J Clin Oncol; 2003 Dec; 26(6):543-9. PubMed ID: 14663369
[TBL] [Abstract][Full Text] [Related]
17. [5-FU based chemoradiotherapy for unresectable locally advanced pancreatic cancer].
Niki T; Soejima T; Yoshikawa T; Yamamoto Y; Fujii O; Ohta Y; Tsuda M; Horita K; Tsujino K; Hirohata S; Fujino Y; Nishisaki H
Gan To Kagaku Ryoho; 2009 Jan; 36(1):63-9. PubMed ID: 19151565
[TBL] [Abstract][Full Text] [Related]
18. Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinoma.
Ishii H; Okada S; Tokuuye K; Nose H; Okusaka T; Yoshimori M; Nagahama H; Sumi M; Kagami Y; Ikeda H
Cancer; 1997 Apr; 79(8):1516-20. PubMed ID: 9118032
[TBL] [Abstract][Full Text] [Related]
19. A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma.
Myerson RJ; Valentini V; Birnbaum EH; Cellini N; Coco C; Fleshman JW; Gambacorta MA; Genovesi D; Kodner IJ; Picus J; Ratkin GA; Read TE
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1299-308. PubMed ID: 11483342
[TBL] [Abstract][Full Text] [Related]
20. Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels.
Abrams RA; Grochow LB; Chakravarthy A; Sohn TA; Zahurak ML; Haulk TL; Ord S; Hruban RH; Lillemoe KD; Pitt HA; Cameron JL; Yeo CJ
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1039-46. PubMed ID: 10421536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
